CYP1B1-AS1 has been confirmed to play an important role in triple-negative breast cancer, lung adenocarcinoma and acute myeloid leukemia, and was associated with the prognosis of these cancers (Cheng et al., 2021; Ren et al., 2021; Vishnubalaji and Alajez, 2021). Here, CYP1B1 is linked to acute myeloid leukemia.